These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19940493)

  • 1. Mechanisms of impaired growth: effect of steroids on bone and cartilage.
    Olney RC
    Horm Res; 2009 Nov; 72 Suppl 1():30-5. PubMed ID: 19940493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of corticosteroids on bone metabolism: a review.
    Mitra R
    PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucocorticoids on the skeleton.
    Canalis E; Pereira RC; Delany AM
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1341-5. PubMed ID: 12510988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
    Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
    J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
    J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute 5-fluorouracil chemotherapy and insulin-like growth factor-I pretreatment on growth plate cartilage and metaphyseal bone in rats.
    Xian CJ; Howarth GS; Cool JC; Foster BK
    Bone; 2004 Sep; 35(3):739-49. PubMed ID: 15336611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histomorphometric analysis of glucocorticoid-induced osteoporosis.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zenari S; Zanatta M; Sella S; Giannini S; Cascio VL
    Micron; 2005; 36(7-8):645-52. PubMed ID: 16243531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.
    Pfeilschifter J; Laukhuf F; Müller-Beckmann B; Blum WF; Pfister T; Ziegler R
    J Clin Invest; 1995 Aug; 96(2):767-74. PubMed ID: 7635970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
    Brixen K; Kassem M; Nielsen HK; Loft AG; Flyvbjerg A; Mosekilde L
    J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth.
    Fisher MC; Meyer C; Garber G; Dealy CN
    Bone; 2005 Dec; 37(6):741-50. PubMed ID: 16183342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects.
    Alesci S; De Martino MU; Ilias I; Gold PW; Chrousos GP
    Neuroimmunomodulation; 2005; 12(1):1-19. PubMed ID: 15756049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IGF-I on PTH effects on bone.
    Lombardi G; Di Somma C; Vuolo L; Guerra E; Scarano E; Colao A
    J Endocrinol Invest; 2010; 33(7 Suppl):22-6. PubMed ID: 20938222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
    Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
    J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts.
    Hilal G; Massicotte F; Martel-Pelletier J; Fernandes JC; Pelletier JP; Lajeunesse D
    J Bone Miner Res; 2001 Apr; 16(4):713-21. PubMed ID: 11315999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of glucocorticoid action in bone cells.
    Delany AM; Dong Y; Canalis E
    J Cell Biochem; 1994 Nov; 56(3):295-302. PubMed ID: 7876321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New drugs with positive effects on bones].
    Zofková I; Kanceva RL
    Cas Lek Cesk; 1997 Jul; 136(15):459-63. PubMed ID: 9340191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor system and the coupling of formation to resorption.
    Hayden JM; Mohan S; Baylink DJ
    Bone; 1995 Aug; 17(2 Suppl):93S-98S. PubMed ID: 8579905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of bone mass by growth hormone.
    Olney RC
    Med Pediatr Oncol; 2003 Sep; 41(3):228-34. PubMed ID: 12868124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.